ENTEROMEDICS
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.
ENTEROMEDICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2002-01-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.enteromedics.com
Total Employee:
11+
Status:
Active
Contact:
(800) 698-2562
Total Funding:
161.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Dan Gladney CEO @ EnteroMedics
CEO
Mark B. Knudson Founder, Chairman, President and Chief Executive Officer @ EnteroMedics
Founder, Chairman, President and Chief Executive Officer
Scott Shikora Chief Medical Officer @ EnteroMedics
Chief Medical Officer
Gregory S. Lea Vice President and Chief Financial Officer @ EnteroMedics
Vice President and Chief Financial Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-10-03 | ReShape Lifesciences | ReShape Lifesciences acquired by EnteroMedics | 61 M USD |
| 2017-05-23 | BarioSurg | BarioSurg acquired by EnteroMedics | N/A |
Investors List
Aberdare Ventures
Aberdare Ventures investment in Post-IPO Equity - EnteroMedics
MPM Capital
MPM Capital investment in Post-IPO Equity - EnteroMedics
Bay City Capital
Bay City Capital investment in Post-IPO Equity - EnteroMedics
Bay City Capital
Bay City Capital investment in Series A - EnteroMedics
Official Site Inspections
http://www.enteromedics.com Semrush global rank: 884.96 K Semrush visits lastest month: 42.03 K
- Host name: 172.67.211.74
- IP address: 172.67.211.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EnteroMedics"
EnteroMedics - Crunchbase Company Profile & Funding
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first …See details»
EnteroMedics - LinkedIn
EnteroMedics | 2,070 followers on LinkedIn. ReShape Lifesciences™ is the weight loss company that offers products and solutions to help people with obesity throughout the treatment continuum.See details»
EnteroMedics changes name to ReShape Lifesciences …
ST. PAUL, Minn., Oct. 23, 2017 /PRNewswire/ — EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat …See details»
EnteroMedics - The Org
EnteroMedics® Inc. (NASDAQ: ETRM) is the developer of in-class weight loss treatments for obesity and obesity related risk factors. Industries. Biotechnology, Health Care + 2. …See details»
EnteroMedics Announces Senior Level Appointments, New …
Jan 6, 2016 With the addition of these new roles, EnteroMedics is shifting its commercial organization toward several, highly focused commercial areas headed by executives with …See details»
EnteroMedics - Contacts, Employees, Board Members, Advisors
EnteroMedics® Inc. (NASDAQ: ETRM) is the developer of in-class weight loss treatments for obesity and obesity related risk factors. ... Experience the new Crunchbase, powered by AI . …See details»
Company EnteroMedics Inc Nasdaq - MarketScreener.com
Executive Committee: EnteroMedics Inc . Manager Title Age Since; Paul Hickey CEO. Chief Executive Officer 60 2022-08-14 Thomas Stankovich CEO. Chief Executive Officer 64 2022 …See details»
EnteroMedics Inc. - VentureRadar
EnteroMedics is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for …See details»
EnteroMedics (USA) Funding: $161.2M - Medical Startups
Mar 27, 2025 EnteroMedics is the developer of in-class weight loss treatments for obesity and obesity related risk...See details»
EnteroMedics Company Profile & Introduction - Tiger Brokers
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other …See details»
EnteroMedics - Products, Competitors, Financials, Employees ...
EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. …See details»
EnteroMedics - 2025 Company Profile, Funding & Competitors
Aug 17, 2021 EnteroMedics is a public company based in Saint Paul (United States), founded in 2002. It operates as a Satiety induction through vagal nerve block. EnteroMedics has raised …See details»
EnteroMedics - Funding, Financials, Valuation & Investors
EnteroMedics is registered under the ticker NASDAQ:ETRM . Their stock opened with $8.00 in its Nov 15, 2007 IPO. EnteroMedics is funded by 3 investors. Aberdare Ventures and MPM …See details»
EnteroMedics Announces Acquisition Of ReShape Medical
Oct 3, 2017 Individuals interested in listening to the conference call may do so by dialing 1-800-860-2442 for domestic callers or 1-412-858-4600 for international callers. To listen to a live …See details»
EnteroMedics Company Overview, Contact Details & Competitors
Oct 18, 2017 FDA Approved Weight Loss Solutions EnteroMedics offers FDA-approved weight loss solutions like the Lap-Band, a safe and effective option covered by most insurance …See details»
Working At EnteroMedics: Company Overview and Culture - Zippia
EnteroMedics Inc. is the developer of vBloc neurometabolic therapy, delivered by a pacemaker-like device called the Maestro Rechargeable System, a first-in-class weight loss treatment for …See details»
EnteroMedics (ETRM) Announces Senior Level ... - Fierce Biotech
Jan 8, 2016 With the addition of these new roles, EnteroMedics is shifting its commercial organization toward several, highly focused commercial areas headed by executives with …See details»
EnteroMedics Inc - SEC.gov
EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other …See details»
EnteroMedics - Tech Stack, Apps, Patents & Trademarks
Feb 2, 2025 The intellectual property of EnteroMedics includes 26 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, …See details»
EnteroMedics, Inc. (EnteroMedics, Inc.) - 药物管线_专利_临床试验_ …
了解EnteroMedics, Inc. (EnteroMedics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的7篇新闻和8篇文献。 ... For instance, according to data published by the World Health …See details»